Overview
Valine is an essential, non-polar, branched-chain amino acid that cannot be synthesized by the human body and must be obtained through the diet. It has a hydrophobic isopropyl side chain and belongs to the branched-chain amino acids group along with leucine and isoleucine.
Valine plays an important role in protein synthesis, muscle growth, and tissue repair. It is a keto-acid precursor and participates in the gluconeogenic pathway, contributing to energy production. Valine is absorbed from the intestine via sodium-dependent transport systems, distributed mainly to muscle and brain, and its catabolism occurs predominantly in muscle tissue, where it is ultimately converted to succinyl-CoA for entry into the tricarboxylic acid cycle.
Symptoms
Abnormal valine levels are associated with neurological, gastrointestinal, musculoskeletal, and metabolic symptoms. Excess valine may present with nausea, vomiting, poor feeding, drowsiness, hyperkinetic movements, ataxia, hypotonia, and muscle weakness. Metabolic manifestations include elevated branched-chain amino acids in plasma and metabolic acidosis, commonly seen in conditions such as maple syrup urine disease. Deficiency of valine leads to fatigue, loss of appetite, difficulty concentrating, and failure to thrive. Neurological symptoms such as head retraction, aimless circling, and a staggering gait may occur, along with muscle weakness, loss of muscle mass, and developmental delay, especially in children.
Causes
Abnormal valine levels are caused by dietary imbalance, metabolic disorders, or impaired amino acid metabolism. Elevated valine is most commonly seen in inherited metabolic disorders such as maple syrup urine disease, valinemia, and hypervalinemia, where branched-chain amino acid catabolism is defective. Liver dysfunction and severe metabolic stress can also contribute to increased levels.
Valine deficiency results from inadequate dietary intake, malnutrition, malabsorption, chronic illness, or increased metabolic demand during growth, infection, or recovery states. Impaired absorption or transport of branched-chain amino acids can further aggravate deficiency.
Risk Factors
Risk factors for abnormal valine levels include inherited disorders of branched-chain amino acid metabolism, the neonatal and infant age group, poor nutritional status, chronic liver disease, and severe illness. Newborns are particularly vulnerable due to inborn errors of metabolism detected through screening programs.
Individuals with prolonged fasting, restrictive diets, or protein-energy malnutrition are at higher risk of deficiency. Improper sample collection, hemolysis, non-fasting samples, or delayed processing can affect laboratory assessment and interpretation of valine levels.
Prevention
Prevention focuses on maintaining adequate dietary intake of valine through protein-rich foods such as meat, fish, eggs, dairy products, legumes, nuts, seeds, and whole grains. Early diagnosis and dietary management of metabolic disorders like maple syrup urine disease help prevent toxic accumulation and neurological damage.
Newborn screening allows timely detection and intervention in high-risk infants. Proper laboratory practices, including fasting sample collection, rapid separation, cooling, and appropriate storage, improve diagnostic accuracy. Nutritional assessment and ongoing monitoring support normal growth, muscle function, and metabolic balance.
